Caribou Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Caribou Biosciences generated cash of -$93,291,000, which is less than the previous year. Cash used in financing activities reached the amount of $154,298,000 last year. Net change in cash is therefore -$7,176,000.
Cash Flow
| 2019 | -32.00M | 27.23M | 172K |
|---|---|---|---|
| 2020 | -33.21M | 6.36M | 1.73M |
| 2021 | -32.51M | -176.39M | 433.42M |
| 2022 | -90.96M | -93.24M | 2.13M |
| 2023 | -93.29M | -68.18M | 154.29M |
CRBU Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 58.38M | 240.46M | 15.95M | 41.07M | 45.67M |
Operating activities | |||||
Net income | -102.07M | -99.42M | -66.92M | -34.30M | -23.43M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.52M | 1.62M | 984K | 900K | 751K |
Stock-based compensation expense | 13.75M | 11.71M | 3.44M | 1.00M | 1.23M |
| Deferred income tax benefit | 13.75M | 11.71M | 3.44M | 1.00M | 1.23M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 805K | 951K | -1.00M | -146K | 617K |
Inventories | 0 | 0 | -2.2M | 1.35M | -2.22M |
Accounts payable | 1.81M | -2.72M | 1.13M | 43K | 1.17M |
Cash generated by operating activities | -93.29M | -90.96M | -32.51M | -33.21M | -32.00M |
Investing activities | |||||
Purchases Of Investments | -394.75M | -339.06M | -173.27M | -10K | 0 |
Investments In Property Plant And Equipment | -11.61M | -7.05M | -3.12M | -1.31M | -884K |
Acquisitions Net | 0 | 600K | 0 | 10K | 0 |
Cash generated by investing activities | -68.18M | -93.24M | -176.39M | 6.36M | 27.23M |
Financing activities | |||||
Common Stock Issued | 152.72M | 2.13M | 321.02M | 270K | 217K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -119K | -113K | -45K |
Cash used in financing activities | 154.29M | 2.13M | 433.42M | 1.73M | 172K |
Net Change In Cash | -7.17M | -182.08M | 224.51M | -25.11M | -4.60M |
Cash at end of period | 51.20M | 58.38M | 240.46M | 15.95M | 41.07M |
| Data source | Data source | Data source |